Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Hartford International Opp HLS IB HBIOX
- NAV / 1-Day Return 16.07 / +0.19 %
- Total Assets 876.1 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment —
- Status Open
- TTM Yield 0.84%
- Turnover 54%
USD | NAV as of Mar 18, 2024 | 1-Day Return as of Mar 18, 2024, 10:18 PM GMT+0
Morningstar’s Analysis HBIOX
Will HBIOX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 24.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 3.59 | 30.5 Mil | Technology |
Samsung Electronics Co Ltd | 3.18 | 27.0 Mil | Technology |
ASML Holding NV | 2.70 | 23.0 Mil | Technology |
Sony Group Corp | 2.50 | 21.2 Mil | Technology |
AstraZeneca PLC | 2.34 | 19.9 Mil | Healthcare |
Novartis AG Registered Shares | 2.23 | 19.0 Mil | Healthcare |
Shell PLC | 2.18 | 18.6 Mil | Energy |
Tencent Holdings Ltd | 2.10 | 17.8 Mil | Communication Services |
Rio Tinto PLC Registered Shares | 2.09 | 17.8 Mil | Basic Materials |
Novo Nordisk A/S Class B | 1.96 | 16.6 Mil | Healthcare |